Can we predict mutant neoepitopes in human cancers for patient-specific vaccine therapy?

Cancer Immunol Res. 2014 Jun;2(6):518-21. doi: 10.1158/2326-6066.CIR-14-0041. Epub 2014 May 2.
No abstract available

Publication types

  • Review

MeSH terms

  • Antigens, Neoplasm / genetics
  • Antigens, Neoplasm / immunology
  • Cancer Vaccines / immunology
  • Cancer Vaccines / therapeutic use*
  • Epitopes, T-Lymphocyte / immunology
  • Histocompatibility Antigens Class I / metabolism
  • Humans
  • Immunity, Cellular / genetics
  • Immunity, Cellular / immunology
  • Immunotherapy, Active / methods*
  • Mutation / immunology
  • Neoplasms / immunology
  • Neoplasms / therapy*
  • Precision Medicine
  • T-Lymphocytes / immunology

Substances

  • Antigens, Neoplasm
  • Cancer Vaccines
  • Epitopes, T-Lymphocyte
  • Histocompatibility Antigens Class I